- FDA approves Cochlear Limited's (COH) Nucleus® Nexa™ System, the world's first smart cochlear implant system with upgradeable firmware.
- The Nucleus 8 Nexa Sound Processor is 9% smaller and 12% lighter, featuring IP68 waterproofing and all-day battery life.
- Commercial availability of the new system, including Nucleus Nexa Implant and Sound Processors, is expected by late Summer 2025.
Cochlear Limited (COH), a global leader in implantable hearing solutions, has gained FDA approval for its innovative Cochlear™ Nucleus® Nexa™ System. This marks a significant milestone as the world's first smart cochlear implant system with upgradeable firmware, allowing users to access future advancements without changing the implant.
The Nucleus 8 Nexa Sound Processor, with the new Power Compact rechargeable battery, is now the smallest and lightest sound processor available, maintaining all-day battery life while being 9% smaller and 12% lighter than previous models. This enhancement is paired with Dynamic Power Management, optimizing battery performance tailored to the user’s needs throughout the day.
The system's new features include internal memory for storing personalized hearing settings, which can be transferred to any compatible sound processor, further ensuring users remain connected even if the processor is lost or damaged. Additionally, the system offers IP68 waterproof certification, facilitating robust performance in various environments.
Included in the product line are the Nucleus Nexa Implant, Nucleus Kanso 3 Nexa Sound Processor, and Nucleus 8 Nexa Sound Processor. Current users of Cochlear's legacy systems can upgrade to the Kanso 3 Sound Processor, although an upgrade to the full Nexa System is not available.
Cochlear plans to make the Nucleus Nexa System commercially available by late Summer 2025. The development represents a groundbreaking advancement in hearing solutions, promising an enhanced auditory experience for users worldwide.
